$6.42 Million is the total value of Copernicus Capital Management, LLC's 15 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | New | ROCKET PHARMACEUTICALS INC | $439,000 | – | 8,000 | +100.0% | 6.84% | – |
| IGMS | New | IGM BIOSCIENCES INC | $353,000 | – | 4,000 | +100.0% | 5.50% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $260,000 | – | 2,000 | +100.0% | 4.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.